KVI Brave Fund - Voice 2 Diabetes (case study)

"Voice 2 Diabetes" centers on a groundbreaking study from Klick Labs that combines voice technology with artificial intelligence to revolutionize diabetes detection. The study, published in 'Mayo Clinic Proceedings: Digital Health', reveals that determining whether a person has Type 2 diabetes could be as easy as having them speak a few sentences into their smartphone.
Klick Labs scientists used six to ten seconds of a person's voice, along with basic health data such as age, sex, height, and weight, to create an AI model with an accuracy of 89 percent for women and 86 percent for men. The study involved 267 participants, both non-diabetic and Type 2 diabetic, who recorded a phrase into their smartphones six times daily for two weeks. From over 18,000 recordings, researchers analyzed 14 acoustic features to identify differences between non-diabetic and Type 2 diabetic individuals.
The research highlights significant vocal variations between individuals with and without Type 2 diabetes. Jaycee Kaufman, the first author of the paper and research scientist at Klick Labs, emphasized that current detection methods require substantial time, travel, and cost, whereas voice technology has the potential to eliminate these barriers entirely. The team at Klick Labs used signal processing to detect changes in pitch and intensity in the voice caused by Type 2 diabetes, which manifested differently for males and females.
The International Diabetes Federation reports that nearly half of the 240 million adults living with diabetes worldwide are unaware they have the condition, and almost 90 percent of diabetic cases are Type 2 diabetes. Current diagnostic tests require visits to healthcare providers, which can be a significant barrier for many. Yan Fossat, vice president of Klick Labs and principal investigator of the study, stated that Klick’s non-intrusive and accessible approach offers the potential to screen vast numbers of people and help identify the large percentage of undiagnosed individuals with Type 2 diabetes.
Fossat underscored the potential of voice technology to revolutionize healthcare practices as an accessible and affordable digital screening tool. The next steps include replicating the study and expanding research into using voice as a diagnostic tool for other conditions such as prediabetes, women's health, and hypertension.
Enabled by over a decade of expertise and investment in machine learning, data science, and artificial intelligence, Klick Labs has made significant strides in various therapeutic areas, including diabetes. Their previous studies have also focused on mathematical modeling to understand glucose regulation, with recent research published in Mayo Clinic Proceedings: Digital Health. The "Voice 2 Diabetes" campaign showcases Klick Labs' commitment to innovation in healthcare, aiming to make diabetes screening more accessible and efficient.
AWARDS
Cannes Lions 2024
- Innovation Grand Prix
- Gold in pharma
CREDITS
Brand: KVI Brave Fund Inc.
Creative Agency: Klick Health, Toronto.
Chief Creative Officer: Rich Levy.
Executive Creative Directors: Bernardo Romero, Tim Jones.
Group Creative Directors: Amy Fortunato, Andrea Bistany.
Vice President: Yan Fossat.
Vice President: Sheryl Steinberg.
Communications Director: Marisa McWilliams.
Communications Manager: Amanda Ferguson.
Producer: Holly Phipps.

[@nichojed]

Fantastic innovation! But what's the idea or/and campaign from the agency's side?